Latest return on equity
TScan Therapeutics Return on equity
Direct answer
TScan Therapeutics's return on equity is -95.8%.
The verified market snapshot reports -95.8%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 9, 2026.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -95.8%
Explore related company data
View TScan Therapeutics's market capitalizationView TScan Therapeutics's price-to-book ratioView TScan Therapeutics's 52-week price rangeView TScan Therapeutics's revenue growthView TScan Therapeutics's profit marginView TScan Therapeutics's debt-to-equity ratioView all TScan Therapeutics key metricsReturn to TScan Therapeutics profile